Evidence map›Paper›PMID 29948070›Full record

ArticleEuropean radiology2018

Efficacy of contrast-enhanced FDG PET/CT in patients awaiting liver transplantation with rising alpha-fetoprotein after bridge therapy of hepatocellular carcinoma.

Rania Refaat, Mohammad Abd Alkhalik Basha, Mohammed Sobhi Hassan, Rasha S Hussein, Ahmed A El Sammak, Dena Abd El Aziz El Sammak, Mohamed Hesham Saleh Radwan, Nahla M Awad, Somaia A Saad El-Din, Engi Elkholy and 4 more

Abstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in European radiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Correlation Between von Hippel-Lindau Gene Expression and Tumor SUVmax and Survival Prognosis in Hepatocellular Carcinoma.Medical science monitor : international medical journal of experimental and clinical research · 2020
    Article
  5. Therapeutic advances in gastroenterology · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Rania RefaatDepartment of Radiodiagnosis, Ain Shams University, Cairo, Egypt.
Mohammad Abd Alkhalik BashaDepartment of Radiodiagnosis, Zagazig University, Zagazig, Egypt. drmohammad_basha@yahoo.com.
Mohammed Sobhi HassanDepartment of Radiodiagnosis, Ain Shams University, Cairo, Egypt.
Rasha S HusseinDepartment of Radiodiagnosis, Ain Shams University, Cairo, Egypt.
Ahmed A El SammakDepartment of Radiodiagnosis, Zagazig University, Zagazig, Egypt.
Dena Abd El Aziz El SammakDepartment of Radiodiagnosis, Zagazig University, Zagazig, Egypt.
Mohamed Hesham Saleh RadwanDepartment of Radiodiagnosis, Zagazig University, Zagazig, Egypt.
Nahla M AwadEarly Cancer Detection Unit, Ain Shams University Hospitals, Cairo, Egypt.
Somaia A Saad El-DinDepartment of Pathology, Ain Shams University, Cairo, Egypt.
Engi ElkholyDepartment of Clinical Oncology, Ain Shams University, Cairo, Egypt.
Dina R D IbrahimDepartment of Clinical Oncology, Ain Shams University, Cairo, Egypt.
Shereen A SalehDepartment of Internal Medicine, Gastroenterology and Hepatology Unit, Ain Shams University, Cairo, Egypt.
Iman F MontasserDepartment of Tropical Medicine, HCC Unit, Ain Shams University, Cairo, Egypt.
Hany SaidDepartment of General Surgery HPB, and Liver Transplantation, Ain Shams Center for Organ Transplantation, Ain Shams University, Cairo, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo assess the diagnostic accuracy and illustrate positive findings of contrast-enhanced fluorine-18 fluoro-D-glucose positron emission tomography/computed tomography ( MATERIALS AND

methodsThis prospective study included 100 patients who were waiting for LT and who previously underwent locoregional therapy (LRT) of HCC. These patients had rising AFP levels on a routine follow-up examination awaiting LT. All patients underwent a contrast-enhanced

resultsContrast-enhanced

conclusionContrast-enhanced KEY POINTS: •

Indexed as

Liver TransplantationAdultAgedalpha-FetoproteinsBiomarkers, TumorCarcinoma, HepatocellularFemaleFluorodeoxyglucose F18Follow-Up StudiesHumansLiver NeoplasmsMaleMiddle AgedPositron Emission Tomography Computed TomographyProspective StudiesRadiopharmaceuticalsalpha-FetoproteinsBiomarkers, TumorFluorodeoxyglucose F18RadiopharmaceuticalsAlpha-fetoproteinFluorodeoxyglucose F18Hepatocellular carcinomaLiver transplantationPositron-emission tomography

Identifiers

PMID29948070

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.